Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Rachiglio AM"'
Autor:
CIARDIELLO, Fortunato, Normanno N, Maiello E, MARTINELLI, Erika, TROIANI, Teresa, Pisconti S, Giuliani F, Barone C, Cartenì G, Rachiglio AM, Montesarchio V, Tonini G, Rizzi D, Cinieri S, Bordonaro R, Febbraro A, ORDITURA, Michele, Fenizia F, Lambiase M, Rinaldi A, Tatangelo F, Botti G, Colucci G., DE VITA, Ferdinando
BACKGROUND: Treatment with anti-epidermal growth factor receptor (EGFR) monoclonal antibodies has been restricted to metastatic colorectal cancer (mCRC) patients with RAS wild-type tumors. Next generation sequencing (NGS) allows the assessment in a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::6d5b12387bc412361fe19531bb1fe1ad
http://hdl.handle.net/11591/184942
http://hdl.handle.net/11591/184942
Autor:
Esposito C, Rachiglio AM, La Porta ML, Sacco A, Roma C, Iannaccone A, Tatangelo F, Forgione L, Pasquale R, Barbaro A, Botti G, Normanno N., CIARDIELLO, Fortunato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::40ebdeacfb28dd549b6d8625d4920b20
http://hdl.handle.net/11591/181448
http://hdl.handle.net/11591/181448
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kelli Bramlett, Marjolijn J. L. Ligtenberg, Kazuko Sakai, Michel Bihl, Nicola Normanno, Alexander Boag, Cecily P. Vaughn, Susan Crocker, Harriet Feilotter, Andrea Mafficini, Varun Bagai, Bastiaan B J Tops, Anna Maria Rachiglio, José Carlos Machado, José Luis Costa, Aldo Scarpa, Ian A Cree, Hélène Blons, Delphine Le Corre, Orla Sheils, Rosella Petraroli, Pierre Laurent-Puig, Henriette M. Kurth, Roy R. L. Bastien, Federica Zito Marino, Astrid Hirschmann, Kazuto Nishio, Anne Reiman
Publikováno v:
BMC Cancer, 18
BMC Cancer
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Cancer
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Background: Gene fusion events resulting from chromosomal rearrangements play an important role in initiation of lung adenocarcinoma. The recent association of four oncogenic driver genes, ALK, ROS1, RET, and NTRK1, as lung tumor predictive biomarker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39997269eacdd1d1a92d42c26f48177b
https://hdl.handle.net/2066/195300
https://hdl.handle.net/2066/195300
Autor:
Filippo Micheli, Alessia Iannaccone, Francesca Fenizia, Antonella De Luca, Francesca Bergantino, Raffaella Pasquale, Cristin Roma, Claudia Esposito, Maria Libera La Porta, Nicola Normanno, Anna Maria Rachiglio, Susan Costantini, Michele Santangelo
Publikováno v:
Journal of cellular biochemistry. 114(3)
Increasing evidence demonstrates that target-based agents are active only in molecularly selected populations of patients. Therefore, the identification of predictive biomarkers has become mandatory to improve the clinical development of these novel
Autor:
Nicola Normanno, Gerardo Botti, Carmine Pinto, R Vincenzo Iaffaioli, Cristin Roma, Fabiana Tatangelo, Oscar Nappi, Anna Maria Rachiglio, Fortunato Ciardiello, Pietro Carotenuto
Aims: Patients with metastatic colorectal carcinoma (mCRC) carrying activating mutations of the KRAS gene do not benefit from treatment with anti-EGF receptor monoclonal antibodies. Therefore, KRAS mutation testing of mCRC patients is mandatory in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cc6ee9ef57ca03156cfc1b16b63e9f8
http://hdl.handle.net/11591/199181
http://hdl.handle.net/11591/199181
Autor:
Nicola Normanno, Anna Maria Rachiglio, Giuseppe Antinolfi, Pietro Carotenuto, Renato Franco, Alfonso Illiano, Francovito Piantedosi, Alessandro Morabito, Gerardo Botti, Antonella De Luca, Cristin Roma, Raffaella Pasquale
Publikováno v:
Pharmacogenomics and personalized medicine
The epidermal growth factor receptor (EGFR) is expressed in the majority of non- small-cell lung cancer (NSCLC). However, only a restricted subgroup of NSCLC patients respond to treatment with the EGFR tyrosine kinase inhibitor (EGFR TKI) gefitinib.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aae62c090c8a3bfdfb573e7eb9bf1d1b
http://hdl.handle.net/11591/328837
http://hdl.handle.net/11591/328837
Autor:
Cardone C; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS 'Fondazione G. Pascale', Naples, Italy., Facchini S; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS 'Fondazione G. Pascale', Naples, Italy., de Stefano A; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS 'Fondazione G. Pascale', Naples, Italy., Rachiglio AM; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS 'Fondazione G. Pascale', Naples, Italy., Avallone A; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS 'Fondazione G. Pascale', Naples, Italy.
Publikováno v:
Cytopathology : official journal of the British Society for Clinical Cytology [Cytopathology] 2024 Jul 31. Date of Electronic Publication: 2024 Jul 31.
Autor:
Frezzetti D; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy., Caridi V; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy., Marra L; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy., Camerlingo R; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy., D'Alessio A; Laboratory of Toxicology Analysis, Department for the Treatment of Addictions, ASL Salerno, 84124 Salerno, Italy., Russo F; Institute of Endocrinology and Experimental Oncology, National Research Council of Italy, 80131 Naples, Italy., Dotolo S; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy., Rachiglio AM; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy., Esposito Abate R; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy., Gallo M; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy., Maiello MR; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy., Morabito A; Thoracic Department, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy., Normanno N; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy., De Luca A; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Apr 29; Vol. 25 (9). Date of Electronic Publication: 2024 Apr 29.
Autor:
Rachiglio AM; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori 'Fondazione G. Pascale'-IRCCS, 80131 Naples, Italy., Forgione L; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori 'Fondazione G. Pascale'-IRCCS, 80131 Naples, Italy., Pasquale R; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori 'Fondazione G. Pascale'-IRCCS, 80131 Naples, Italy., Barone CA; Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy., Maiello E; IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy., Antonuzzo L; Medical Oncology Unit, Azienda Ospedaliero Universitaria Careggi, 50134 Florence, Italy., Cassata A; Medical Oncology Unit, Istituto Nazionale Tumori 'Fondazione G. Pascale'-IRCCS, 80131 Naples, Italy., Tonini G; Medical Oncology Unit, Università Campus Bio-Medico, 00128 Rome, Italy., Bordonaro R; Medical Oncology Unit, ARNAS Garibaldi, 95122 Catania, Italy., Rosati G; Medical Oncology Unit, Ospedale San Carlo, 85100 Potenza, Italy., Zaniboni A; Fondazione Poliambulanza, 25124 Brescia, Italy., Lonardi S; Medical Oncology IOV, 35128 Padua, Italy., Ferrari D; Ospedale S. Paolo, 20142 Milan, Italy., Frassineti GL; Medical Oncology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy., Tamberi S; Ospedale per Gli Infermi, 48018 Faenza, Italy., Pisconti S; Medical Oncology Division, S. Giuseppe Moscati Hospital, 74010 Taranto, Italy., Di Fabio F; Medical Oncology Unit, S. Orsola-Malpighi Hospital, 40138 Bologna, Italy., Roma C; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori 'Fondazione G. Pascale'-IRCCS, 80131 Naples, Italy., Orlandi A; Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy., Latiano T; IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy., Damato A; Medical Oncology Unit, Clinical Cancer Center, AUSL-IRCCS Reggio Emilia, 42122 Reggio Emilia, Italy.; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy., Tortora G; Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy., Pinto C; Medical Oncology Unit, Clinical Cancer Center, AUSL-IRCCS Reggio Emilia, 42122 Reggio Emilia, Italy., Normanno N; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori 'Fondazione G. Pascale'-IRCCS, 80131 Naples, Italy.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Feb 18; Vol. 14 (4). Date of Electronic Publication: 2022 Feb 18.